Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...
Novo’s obesity drug sales nearly doubled outside the U.S. during the quarter as global demand continued to rise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback